Biome Australia posts strong probiotic growth, affirms FY26 profit outlook

The latest update is out from Biome Australia Ltd ( (AU:BIO) ).

Biome Australia reported that consumer sell-through of its Activated Probiotics surpassed one million boxes on a rolling 12‑month basis in the March 2026 quarter, with the brand identified as the fastest‑growing probiotic label in Australian community pharmacies and its Biome Daily product now ranked second by units and value. The company highlighted its progress toward delivering its 100 millionth dose within FY26, maintained expectations of profitability for the year, noted a net increase in cash to $3.39 million, and flagged upcoming milestones including a 240‑participant BMB18 clinical trial, a lodged BMB18 patent and an anticipated update on onshore Australian manufacturing, while also issuing a revised Appendix 4C to correct minor formatting errors without altering reported operating cash flow totals.

Biome’s brand marketing spend was disclosed at about 6.5% of its sales, advertising and marketing cost centre year‑to‑date, with commitments to greater transparency in future reporting periods. The company views the BMB18 patent and planned Australian manufacturing as central to its long‑term intellectual property strategy and Vision 27 agenda, reinforcing its competitive positioning as it scales both domestically and in new overseas practitioner channels.

The most recent analyst rating on (AU:BIO) stock is a Buy with a A$1.00 price target. To see the full list of analyst forecasts on Biome Australia Ltd stock, see the AU:BIO Stock Forecast page.

More about Biome Australia Ltd

Biome Australia Limited is a health and wellness company focused on probiotics, marketing its Activated Probiotics range primarily through Australian community pharmacies and healthcare practitioner channels. The company is expanding internationally, with a recent national launch in Canada via Fullscript, targeting North America’s largest practitioner distribution network.

Average Trading Volume: 190,190

Technical Sentiment Signal: Hold

Current Market Cap: A$74.1M

For an in-depth examination of BIO stock, go to TipRanks’ Overview page.